share_log

Truist Securities Maintains Buy on Collegium Pharmaceutical, Raises Price Target to $40

Moomoo 24/7 ·  Feb 26 08:20

Truist Securities analyst Les Sulewski maintains Collegium Pharmaceutical (NASDAQ:COLL) with a Buy and raises the price target from $37 to $40.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment